← Open Payments lookup

KATHRYN EVANS: Open Payments

NPI 1528434214 · GREENWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,063 in 58 payments from 12 companies in 2025. Trend: 2023 $942 · 2024 $1,055 · 2025 $1,063

Food & beverage: $1,063
CompanyPaymentsAmount
ABBVIE INC.19$276
Madrigal Pharmaceuticals10$217
Janssen Biotech, Inc.9$182
Ardelyx, Inc.8$149
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$60
Octapharma USA, Inc.2$45
Takeda Pharmaceuticals U.S.A., Inc.2$35
Aimmune Therapeutics, Inc.1$24
QOL Medical, LLC1$23
Novo Nordisk Inc1$19

Products named: REZDIFFRA, TREMFYA, IBSRELA, CREON, VIBERZI, XIFAXAN, PANZYGA, RINVOQ.

Industry payments across MS — which companies pay providers there.